Screening/ Baseline | Midpoint | Endpointa | Follow-up | |
---|---|---|---|---|
Visit | T1 Study initiation | T2 3-weeks | T3 5-weeks / study endpoint | T4 Within 2 weeks of T3 |
Demographics | ||||
Clinical diagnosis of mild or major NCD due to AD or mixed AD/vascular disease following the DSM-5 criteria by a psychiatrist | X | |||
Demographics | X | |||
Surgical and health history | X | |||
Comorbid Illnesses and concomitant medications | X | X | X | |
Sleep, caffeine, alcohol intake, smoking status | X | X | X | |
Standardized mini-mental state examination | X | |||
Canadian society of exercise physiology physical activity readiness questionnaire-plus | X | |||
Outcomes | ||||
Montreal cognitive assessment | X | X | X | |
Word recognition task | X | X | X | |
Word recall task | X | X | X | |
n-back | X | X | X | |
Neuropsychiatric inventory | X | X | X | |
Blood biomarkers | X | X | X | |
Safety | ||||
Adverse Events | X | X | X | |
Other | ||||
Leisure-time exercise questionnaireb | X | X | X | |
Follow-up assessment with qualified investigator or designated qualified physician | X |